Tirzepatide
11 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Tirzepatide for alcoholism | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Tirzepatide for diabetes mellitus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Tirzepatide for dyslipidemias | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for heart failure, systolic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for hypertension | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for metabolic diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tirzepatide for metabolic syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Tirzepatide for obesity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 23 |
| Tirzepatide for prediabetic state | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Tirzepatide for renal insufficiency, chronic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |